Naudingos nuorodos
Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

The impact of the COVID-19 pandemic on European health systems will make it necessary for sponsors to adjust how they manage clinical trials and the people who participate in these trials.

 Sponsors are advised to follow the recently published guidance by the European Commission and the European Medicines Agency (EMA):



Guidance for sponsors published by SMCA of Lithuania (in Lithuanian language).